APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contrast Agents

Contrast agents (or contrast media) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Contrast agents (or contrast media) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure.

Selected research

Market Outlook & Growth Opportunities

Global Contrast Agents Market Outlook and Growth Opportunities 2026

21 December 2025190 pages

Choose your research edition.

Industry ResearchContrast Agents Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Contrast Agents Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contrast Agents Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Contrast Agents Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Contrast agents (or contrast media) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure.

Global Contrast Agents key players include GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, etc. Global top four manufacturers hold a share over 75%.

Asia-Pacific is the largest market, with a share over 40%, followed by Europe, and North America, both have a share over 50 percent.

Read the full market overview

In terms of product, X-ray and CT is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospitals, followed by Clinics.

This report provides an overview of the global Contrast Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Contrast Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Contrast Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Contrast Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Contrast Agents Segment by Company

GE Healthcare

Bayer

Bracco Imaging

Guerbet Group

Hengrui Medicine

Lantheus

YRPG

BeiLu Pharma

Contrast Agents Segment by Type

X-ray and CT

MRI

Ultrasound

Contrast Agents Segment by Application

Hospitals

Clinics

Contrast Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Contrast Agents status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Contrast Agents market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Contrast Agents significant trends, drivers, influence factors in global and regions.

6. To analyze Contrast Agents competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contrast Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Contrast Agents market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Contrast Agents industry.

Chapter 3: Detailed analysis of Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Contrast Agents in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Contrast Agents Industry Trends Table 2. Contrast Agents Industry Drivers Table 3. Contrast Agents Industry Opportunities and Challenges Table 4. Contrast Agents Industry Restraints Table 5. Global Contrast Agents Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Contrast Agents Revenue Share by Company (2021-2026) Table 7. Global Contrast Agents Sales Volume by Company (K Dose) & (2021-2026) Table 8. Global Contrast Agents Sales Volume Share by Company (2021-2026) Table 9. Global Contrast Agents Average Price (USD/Dose) of Company (2021-2026) Table 10. Global Contrast Agents Company Ranking, (2024-2026) & (USD Million) Table 11. Global Contrast Agents Key Company Manufacturing Base & Headquarters Table 12. Global Contrast Agents Company, Product Type & Application Table 13. Global Contrast Agents Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Contrast Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of X-ray and CT Table 18. Significant Companies of MRI Table 19. Significant Companies of Ultrasound Table 20. Global Contrast Agents Sales Volume by Type 2021 VS 2025 VS 2032 (K Dose) Table 21. Global Contrast Agents Sales Volume by Type (2021-2026) & (K Dose) Table 22. Global Contrast Agents Sales Volume by Type (2027-2032) & (K Dose) Table 23. Global Contrast Agents Sales Volume Share by Type (2021-2026) Table 24. Global Contrast Agents Sales Volume Share by Type (2027-2032) Table 25. Global Contrast Agents Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Contrast Agents Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Contrast Agents Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Contrast Agents Sales Value Share by Type (2021-2026) Table 29. Global Contrast Agents Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Clinics Table 32. Global Contrast Agents Sales Volume by Application 2021 VS 2025 VS 2032 (K Dose) Table 33. Global Contrast Agents Sales Volume by Application (2021-2026) & (K Dose) Table 34. Global Contrast Agents Sales Volume by Application (2027-2032) & (K Dose) Table 35. Global Contrast Agents Sales Volume Share by Application (2021-2026) Table 36. Global Contrast Agents Sales Volume Share by Application (2027-2032) Table 37. Global Contrast Agents Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Contrast Agents Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Contrast Agents Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Contrast Agents Sales Value Share by Application (2021-2026) Table 41. Global Contrast Agents Sales Value Share by Application (2027-2032) Table 42. Global Contrast Agents Sales by Region: 2021 VS 2025 VS 2032 (K Dose) Table 43. Global Contrast Agents Sales by Region (2021-2026) & (K Dose) Table 44. Global Contrast Agents Sales Market Share by Region (2021-2026) Table 45. Global Contrast Agents Sales by Region (2027-2032) & (K Dose) Table 46. Global Contrast Agents Sales Market Share by Region (2027-2032) Table 47. Global Contrast Agents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Contrast Agents Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Contrast Agents Sales Value Share by Region (2021-2026) Table 50. Global Contrast Agents Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Contrast Agents Sales Value Share by Region (2027-2032) Table 52. Global Contrast Agents Market Average Price (USD/Dose) by Region (2021-2026) Table 53. Global Contrast Agents Market Average Price (USD/Dose) by Region (2027-2032) Table 54. Global Contrast Agents Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Table 55. Global Contrast Agents Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Contrast Agents Sales by Country (2021-2026) & (K Dose) Table 57. Global Contrast Agents Sales Market Share by Country (2021-2026) Table 58. Global Contrast Agents Sales by Country (2027-2032) & (K Dose) Table 59. Global Contrast Agents Sales Market Share by Country (2027-2032) Table 60. Global Contrast Agents Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Contrast Agents Sales Value Market Share by Country (2021-2026) Table 62. Global Contrast Agents Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Contrast Agents Sales Value Market Share by Country (2027-2032) Table 64. GE Healthcare Company Information Table 65. GE Healthcare Business Overview Table 66. GE Healthcare Contrast Agents Sales (K Dose), Value (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 67. GE Healthcare Contrast Agents Product Portfolio Table 68. GE Healthcare Recent Development Table 69. Bayer Company Information Table 70. Bayer Business Overview Table 71. Bayer Contrast Agents Sales (K Dose), Value (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 72. Bayer Contrast Agents Product Portfolio Table 73. Bayer Recent Development Table 74. Bracco Imaging Company Information Table 75. Bracco Imaging Business Overview Table 76. Bracco Imaging Contrast Agents Sales (K Dose), Value (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 77. Bracco Imaging Contrast Agents Product Portfolio Table 78. Bracco Imaging Recent Development Table 79. Guerbet Group Company Information Table 80. Guerbet Group Business Overview Table 81. Guerbet Group Contrast Agents Sales (K Dose), Value (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 82. Guerbet Group Contrast Agents Product Portfolio Table 83. Guerbet Group Recent Development Table 84. Hengrui Medicine Company Information Table 85. Hengrui Medicine Business Overview Table 86. Hengrui Medicine Contrast Agents Sales (K Dose), Value (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 87. Hengrui Medicine Contrast Agents Product Portfolio Table 88. Hengrui Medicine Recent Development Table 89. Lantheus Company Information Table 90. Lantheus Business Overview Table 91. Lantheus Contrast Agents Sales (K Dose), Value (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 92. Lantheus Contrast Agents Product Portfolio Table 93. Lantheus Recent Development Table 94. YRPG Company Information Table 95. YRPG Business Overview Table 96. YRPG Contrast Agents Sales (K Dose), Value (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 97. YRPG Contrast Agents Product Portfolio Table 98. YRPG Recent Development Table 99. BeiLu Pharma Company Information Table 100. BeiLu Pharma Business Overview Table 101. BeiLu Pharma Contrast Agents Sales (K Dose), Value (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 102. BeiLu Pharma Contrast Agents Product Portfolio Table 103. BeiLu Pharma Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Contrast Agents Distributors List Table 107. Contrast Agents Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Contrast Agents Product Image Figure 2. Global Contrast Agents Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 4. Global Contrast Agents Sales (2021-2032) & (K Dose) Figure 5. Global Contrast Agents Sales Average Price (USD/Dose) & (2021-2032) Figure 6. Global Contrast Agents Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. X-ray and CT Image Figure 10. MRI Image Figure 11. Ultrasound Image Figure 12. Global Contrast Agents Sales Volume by Type (2021 VS 2025 VS 2032) & (K Dose) Figure 13. Global Contrast Agents Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Contrast Agents Sales Volume Share by Type (2021-2032) Figure 15. Global Contrast Agents Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Contrast Agents Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Contrast Agents Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Global Contrast Agents Sales Volume by Application (2021 VS 2025 VS 2032) & (K Dose) Figure 21. Global Contrast Agents Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Contrast Agents Sales Volume Share by Application (2021-2032) Figure 23. Global Contrast Agents Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Contrast Agents Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Contrast Agents Sales Value Share by Application (2021-2032) Figure 26. Global Contrast Agents Sales by Region: 2021 VS 2025 VS 2032 (K Dose) Figure 27. Global Contrast Agents Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Contrast Agents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Contrast Agents Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 31. North America Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 37. South America Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Contrast Agents Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Contrast Agents Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • X-ray and CT
  • MRI
  • Ultrasound
Applications
  • Hospitals
  • Clinics
Companies covered
  • GE Healthcare
  • Bayer
  • Bracco Imaging
  • Guerbet Group
  • Hengrui Medicine
  • Lantheus
  • YRPG
  • BeiLu Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Contrast Agents Sales Value (2021-2032)
  4. 1.2.2 Global Contrast Agents Sales Volume (2021-2032)
  5. 1.2.3 Global Contrast Agents Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Contrast Agents Market Dynamics
  1. 2.1 Contrast Agents Industry Trends
  2. 2.2 Contrast Agents Industry Drivers
  3. 2.3 Contrast Agents Industry Opportunities and Challenges
  4. 2.4 Contrast Agents Industry Restraints
3 Contrast Agents Market by Company
  1. 3.1 Global Contrast Agents Company Revenue Ranking in 2025
  2. 3.2 Global Contrast Agents Revenue by Company (2021-2026)
  3. 3.3 Global Contrast Agents Sales Volume by Company (2021-2026)
  4. 3.4 Global Contrast Agents Average Price by Company (2021-2026)
  5. 3.5 Global Contrast Agents Company Ranking (2024-2026)
  6. 3.6 Global Contrast Agents Company Manufacturing Base and Headquarters
  7. 3.7 Global Contrast Agents Company Product Type and Application
  8. 3.8 Global Contrast Agents Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Contrast Agents Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Contrast Agents Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Contrast Agents Market by Type
  1. 4.1 Contrast Agents Type Introduction
  2. 4.1.1 X-ray and CT
  3. 4.1.2 MRI
  4. 4.1.3 Ultrasound
  5. 4.2 Global Contrast Agents Sales Volume by Type
  6. 4.2.1 Global Contrast Agents Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Contrast Agents Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Contrast Agents Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Contrast Agents Sales Value by Type
  10. 4.3.1 Global Contrast Agents Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Contrast Agents Sales Value by Type (2021-2032)
  12. 4.3.3 Global Contrast Agents Sales Value Share by Type (2021-2032)
5 Contrast Agents Market by Application
  1. 5.1 Contrast Agents Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Contrast Agents Sales Volume by Application
  5. 5.2.1 Global Contrast Agents Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Contrast Agents Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Contrast Agents Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Contrast Agents Sales Value by Application
  9. 5.3.1 Global Contrast Agents Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Contrast Agents Sales Value by Application (2021-2032)
  11. 5.3.3 Global Contrast Agents Sales Value Share by Application (2021-2032)
6 Contrast Agents Regional Sales and Value Analysis
  1. 6.1 Global Contrast Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Contrast Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Contrast Agents Sales by Region: 2021-2026
  4. 6.2.2 Global Contrast Agents Sales by Region (2027-2032)
  5. 6.3 Global Contrast Agents Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Contrast Agents Sales Value by Region (2021-2032)
  7. 6.4.1 Global Contrast Agents Sales Value by Region: 2021-2026
  8. 6.4.2 Global Contrast Agents Sales Value by Region (2027-2032)
  9. 6.5 Global Contrast Agents Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Contrast Agents Sales Value (2021-2032)
  12. 6.6.2 North America Contrast Agents Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Contrast Agents Sales Value (2021-2032)
  15. 6.7.2 Europe Contrast Agents Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Contrast Agents Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Contrast Agents Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Contrast Agents Sales Value (2021-2032)
  21. 6.9.2 South America Contrast Agents Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Contrast Agents Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Contrast Agents Sales Value Share by Country, 2025 VS 2032
7 Contrast Agents Country-level Sales and Value Analysis
  1. 7.1 Global Contrast Agents Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Contrast Agents Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Contrast Agents Sales by Country (2021-2032)
  4. 7.3.1 Global Contrast Agents Sales by Country (2021-2026)
  5. 7.3.2 Global Contrast Agents Sales by Country (2027-2032)
  6. 7.4 Global Contrast Agents Sales Value by Country (2021-2032)
  7. 7.4.1 Global Contrast Agents Sales Value by Country (2021-2026)
  8. 7.4.2 Global Contrast Agents Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Contrast Agents Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Contrast Agents Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Contrast Agents Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Contrast Agents Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Contrast Agents Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Contrast Agents Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Contrast Agents Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Contrast Agents Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Contrast Agents Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Contrast Agents Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Contrast Agents Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Contrast Agents Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Contrast Agents Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Contrast Agents Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Contrast Agents Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Contrast Agents Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Contrast Agents Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Contrast Agents Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Contrast Agents Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Contrast Agents Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Contrast Agents Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Contrast Agents Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Contrast Agents Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Contrast Agents Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Contrast Agents Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Contrast Agents Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Contrast Agents Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Contrast Agents Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Contrast Agents Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Contrast Agents Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Contrast Agents Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Contrast Agents Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Contrast Agents Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Contrast Agents Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Contrast Agents Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Contrast Agents Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Contrast Agents Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Contrast Agents Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Contrast Agents Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Contrast Agents Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Contrast Agents Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Contrast Agents Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Contrast Agents Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Contrast Agents Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Contrast Agents Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Contrast Agents Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Contrast Agents Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Contrast Agents Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Contrast Agents Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Contrast Agents Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Contrast Agents Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Contrast Agents Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Contrast Agents Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Contrast Agents Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Contrast Agents Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Contrast Agents Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Contrast Agents Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Contrast Agents Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Contrast Agents Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Contrast Agents Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Contrast Agents Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Contrast Agents Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Contrast Agents Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Contrast Agents Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Contrast Agents Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Contrast Agents Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Contrast Agents Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Contrast Agents Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Contrast Agents Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Contrast Agents Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Contrast Agents Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Contrast Agents Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Contrast Agents Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Contrast Agents Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Contrast Agents Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Contrast Agents Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Contrast Agents Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Contrast Agents Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Contrast Agents Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Contrast Agents Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Contrast Agents Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Contrast Agents Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Contrast Agents Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Contrast Agents Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GE Healthcare
  2. 8.1.1 GE Healthcare Company Information
  3. 8.1.2 GE Healthcare Business Overview
  4. 8.1.3 GE Healthcare Contrast Agents Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GE Healthcare Contrast Agents Product Portfolio
  6. 8.1.5 GE Healthcare Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Contrast Agents Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Contrast Agents Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Bracco Imaging
  14. 8.3.1 Bracco Imaging Company Information
  15. 8.3.2 Bracco Imaging Business Overview
  16. 8.3.3 Bracco Imaging Contrast Agents Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bracco Imaging Contrast Agents Product Portfolio
  18. 8.3.5 Bracco Imaging Recent Developments
  19. 8.4 Guerbet Group
  20. 8.4.1 Guerbet Group Company Information
  21. 8.4.2 Guerbet Group Business Overview
  22. 8.4.3 Guerbet Group Contrast Agents Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Guerbet Group Contrast Agents Product Portfolio
  24. 8.4.5 Guerbet Group Recent Developments
  25. 8.5 Hengrui Medicine
  26. 8.5.1 Hengrui Medicine Company Information
  27. 8.5.2 Hengrui Medicine Business Overview
  28. 8.5.3 Hengrui Medicine Contrast Agents Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hengrui Medicine Contrast Agents Product Portfolio
  30. 8.5.5 Hengrui Medicine Recent Developments
  31. 8.6 Lantheus
  32. 8.6.1 Lantheus Company Information
  33. 8.6.2 Lantheus Business Overview
  34. 8.6.3 Lantheus Contrast Agents Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lantheus Contrast Agents Product Portfolio
  36. 8.6.5 Lantheus Recent Developments
  37. 8.7 YRPG
  38. 8.7.1 YRPG Company Information
  39. 8.7.2 YRPG Business Overview
  40. 8.7.3 YRPG Contrast Agents Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 YRPG Contrast Agents Product Portfolio
  42. 8.7.5 YRPG Recent Developments
  43. 8.8 BeiLu Pharma
  44. 8.8.1 BeiLu Pharma Company Information
  45. 8.8.2 BeiLu Pharma Business Overview
  46. 8.8.3 BeiLu Pharma Contrast Agents Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 BeiLu Pharma Contrast Agents Product Portfolio
  48. 8.8.5 BeiLu Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Contrast Agents Value Chain Analysis
  2. 9.1.1 Contrast Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Contrast Agents Sales Mode & Process
  6. 9.2 Contrast Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Contrast Agents Distributors
  9. 9.2.3 Contrast Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst